Company / Total Assets
Terns Pharmaceuticals, Inc. Total Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$363.9M
FY2024
5-year range
$92.3M / $363.9M
FY2020-FY2024
Trend
+35.5%
vs FY2023
Sector context
#162 of 215
Health Care
What the data says
Terns Pharmaceuticals, Inc.'s total assets of $364M is lower than 75% of companies in the Health Care sector (FY2024). Improved from $287M to $364M over the past 2 years.
Based on SEC 10-K filings.
$364M in FY2024 with a 3-year CAGR of +29.4%.
Improved from $287M to $364M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +29.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 215This company $363.9M Sector average $7.5B
▼
-95.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +29.4%, indicating consistent growth.
- In FY2024, total assets increased 35.5% year-over-year.
- Ranks #162 out of 215 companies in the Health Care sector.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $363.9M | +35.5% |
| FY2023 | $268.5M | -6.4% |
| FY2022 | $287.0M | +70.8% |
| FY2021 | $168.1M | +82.1% |
| FY2020 | $92.3M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026